The chemotherapy and/or radiation given to patients before a stem cell transplant compromise immunity and leave patients vulnerable to infections. This presentation describes major infection risks and effective responses to them. Many thanks to Takeda Pharmaceutical Company whose support, in part, made this presentation possible.

People who undergo a stem cell transplant or CAR T-cell therapy have an increased risk of infection after treatment. This presentation discusses who’s at risk, when infections typically arise, steps taken by transplant teams to avoid and treat infections and steps patients can take to reduce their risk of developing a serious infection.

Distintos tipos de infecciones pueden ocurrir después de un trasplante y pueden complicar la recuperación de los pacientes. Esta presentación describe los riesgos de infecciones después de un trasplante, las terapias para tratarlas, y algunas medidas para prevenirlas.

Infections after Transplant Wednesday, May 3, 2023 Presenter: Jennifer Cuellar-Rodriguez MD, National Institutes of Health Transplant and Cellular Therapy Clinical Program The presentation is 32 minutes long followed by 26